Skip to content

Evaluation of Predictive Factors for Recurrence of Persistent Atrial Fibrillation After Ablation

Evaluation of Predictive Factors for Recurrence of Persistent Atrial Fibrillation After Ablation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06620575
Acronym
FAIR
Enrollment
542
Registered
2024-10-01
Start date
2023-03-29
Completion date
2024-04-30
Last updated
2024-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

This is a single-center, retrospective, observational study based on data extracted from the medical records of patients who underwent a procedure for persistent atrial fibrillation ablation.

Interventions

PROCEDUREAtrial fibrillation ablation

Persistent atrial fibrillation ablation

Sponsors

GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient aged 18 years or older, who has been informed about the research * Patient who underwent a procedure for persistent atrial fibrillation ablation at Clairval Hospital since January 2014 * Patient for whom data regarding the ablation procedure are available

Exclusion criteria

* Patient under legal protection, guardianship, or conservatorship * Patient who has expressed opposition to the use of their medical data (by completing and returning the opt-out form provided)

Design outcomes

Primary

MeasureTime frameDescription
Recurrence of persistent atrial fibrillationMonth 12The main objective of the study is to assess to what extent patient characteristics and conditions during the atrial fibrillation ablation procedure can identify predictive factors for recurrence. Recurrence (Yes/No) is the outcome variable to be explained.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026